Retail Clinician special report focuses on patient-centered care
NEW YORK Drug Store News’ sister publication, Retail Clinician, has issued a special report on an exclusive study conducted by Take Care Health Systems in conjunction with Gallup Consulting that measured patient engagement levels among Take Care Clinic visitors, with an eye toward elevating the patient experience.
The report, which is anchored by the original white paper — written by Sharon Glave Frazee, Ph.D., VP corporate healthcare analytics and research team for Walgreens, along with John H. Fleming, Ph.D., principal, chief scientist customer engagement and humansigma®, Gallup, and Margaret Ozan Rafferty, R.N., M.H.A., M.B.A., healthcare global practice leader for Gallup — and also includes an interview with Take Care CEO Peter Miller discussing the significance of the findings and what it means both for Walgreens and Take Care, and the impact Take Care’s unusually high levels of patient engagement is having on clinic traffic.
A copy of the report can be downloaded here.
Walgreens to acquire pharmacy business, other assets from Memphis USA Drug stores
DEERFIELD, Ill. Walgreens reached an agreement with USA Drug to acquire the prescription files and other assets of 17 Ike’s and Super D drug stores in the Memphis area.
Walgreens will purchase the prescription files at each of the 17 locations and transfer them to nearby Walgreens pharmacies. Patients whose prescriptions are being transferred will be notified by letter once the transaction has been completed later this month.
In related news, Walgreens currently is in negotiations with USA Drug to acquire two Ike’s drug stores. Walgreens said it would most likely staff most of the store positions with the existing employees.
The acquisition is subject to certain customary terms and conditions. Financial terms of the transaction were not disclosed.
“We have a long history of providing high quality pharmacy services in the Memphis area with our first store in the city opening in 1927,” said Walgreens market VP Connie Latta. “Our staffs are ready to make the transition as seamless as possible for our new customers. We look forward to introducing them to the unique offerings that have made Walgreens one of the country’s most trusted providers of health and wellness services and basic needs.”
PhRMA names new chairman
WASHINGTON The Pharmaceutical Research and Manufacturers of America elected Pfizer president and CEO Jeffrey Kindler as its board chairman Thursday at the trade organization’s annual meeting in Washington.
PhRMA also elected Sanofi-Aventis CEO Christopher Viehbacher as chairmen-elect of the board of directors and Eli Lilly & Co. president, CEO and chairman John Lechleiter as board treasurer. Kindler succeeds AstraZeneca executive director and CEO David Brennan as chairman.
“Great leadership requires patients, decisiveness, intelligence, execution and compassion,” PhRMA president and CEO Billy Tauzin said. “David encompasses all of these qualities and much more.”